Department of Pharmacology, Yale University School of Medicine, New Haven, CT 06520, USA.
J Biol Chem. 2010 Jul 30;285(31):24099-107. doi: 10.1074/jbc.M110.128470. Epub 2010 May 19.
CCM3 mutations are associated with cerebral cavernous malformation (CCM), a disease affecting 0.1-0.5% of the human population. CCM3 (PDCD10, TFAR15) is thought to form a CCM complex with CCM1 and CCM2; however, the molecular basis for these interactions is not known. We have determined the 2.5 A crystal structure of CCM3. This structure shows an all alpha-helical protein containing two domains, an N-terminal dimerization domain with a fold not previously observed, and a C-terminal focal adhesion targeting (FAT)-homology domain. We show that CCM3 binds CCM2 via this FAT-homology domain and that mutation of a highly conserved FAK-like hydrophobic pocket (HP1) abrogates CCM3-CCM2 interaction. This CCM3 FAT-homology domain also interacts with paxillin LD motifs using the same surface, and partial CCM3 co-localization with paxillin in cells is lost on HP1 mutation. Disease-related CCM3 truncations affect the FAT-homology domain suggesting a role for the FAT-homology domain in the etiology of CCM.
CCM3 突变与脑内海绵状血管畸形(CCM)有关,该病影响人类的 0.1-0.5%。CCM3(PDCD10,TFAR15)被认为与 CCM1 和 CCM2 形成 CCM 复合物;然而,这些相互作用的分子基础尚不清楚。我们已经确定了 CCM3 的 2.5 A 晶体结构。该结构显示了一种全α螺旋蛋白,包含两个结构域,一个 N 端二聚化结构域,具有以前未观察到的折叠,和一个 C 端黏着斑靶向(FAT)同源结构域。我们表明 CCM3 通过该 FAT 同源结构域与 CCM2 结合,并且高度保守的 Fak 样疏水性口袋(HP1)的突变会破坏 CCM3-CCM2 相互作用。该 CCM3 FAT 同源结构域还与整联蛋白 LD 基序相互作用,使用相同的表面,并且 HP1 突变时细胞中部分 CCM3 与整联蛋白的共定位丢失。与疾病相关的 CCM3 截断影响 FAT 同源结构域,表明 FAT 同源结构域在 CCM 的发病机制中起作用。